ArticleNature communications2024

Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models.

Lays Cordeiro Guimaraes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.